Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
74.01
+0.06 (0.08%)
Oct 28, 2025, 4:00 PM EDT - Market closed
Hologic Market Cap
Hologic has a market cap or net worth of $16.46 billion as of October 29, 2025. Its market cap has decreased by -11.20% in one year.
Market Cap
16.46B
Enterprise Value
17.10B
1-Year Change
-11.20%
Ranking
Category
Stock Price
$74.01
Market Cap Chart
Since December 1, 1998, Hologic's market cap has increased from $167.20M to $16.46B, an increase of 9,745.25%. That is a compound annual growth rate of 18.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 16.46B | 0.62% |
| Dec 31, 2024 | 16.36B | -4.60% |
| Dec 29, 2023 | 17.15B | -6.76% |
| Dec 30, 2022 | 18.39B | -4.46% |
| Dec 31, 2021 | 19.25B | 2.84% |
| Dec 31, 2020 | 18.72B | 33.70% |
| Dec 31, 2019 | 14.00B | 17.78% |
| Dec 31, 2018 | 11.89B | 0.86% |
| Dec 29, 2017 | 11.79B | 5.59% |
| Dec 30, 2016 | 11.16B | 1.98% |
| Dec 31, 2015 | 10.95B | 46.89% |
| Dec 31, 2014 | 7.45B | 22.07% |
| Dec 31, 2013 | 6.10B | 14.36% |
| Dec 31, 2012 | 5.34B | 15.86% |
| Dec 30, 2011 | 4.61B | -5.80% |
| Dec 31, 2010 | 4.89B | 30.76% |
| Dec 31, 2009 | 3.74B | 11.69% |
| Dec 31, 2008 | 3.35B | -61.07% |
| Dec 31, 2007 | 8.60B | 244.89% |
| Dec 29, 2006 | 2.49B | 48.24% |
| Dec 30, 2005 | 1.68B | 195.02% |
| Dec 31, 2004 | 570.40M | 64.62% |
| Dec 31, 2003 | 346.50M | 45.10% |
| Dec 31, 2002 | 238.80M | 62.34% |
| Dec 31, 2001 | 147.10M | 79.39% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 449.42B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |